Serum fatty-acid composition and the risk of Alzheimer’s disease: a longitudinal population-based study

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Clinical Nutrition

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/ejcn.2012.63PMID 22713770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain.

  2011cited by this paper
• Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

  2010cited by this paper
• Food combination and Alzheimer disease risk: a protective diet.

  2010cited by this paper
• Omega-3 Fatty Acids, Cognitive Decline, and Alzheimer's Disease: A Critical Review and Evaluation of the Literature

  2010cited by this paper
• Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

  2010cited by this paper
• Multiple imputation for estimating the risk of developing dementia and its impact on survival

  2010cited by this paper
• Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging.

  2009cited by this paper
• The primary preventive study in Uppsala. Fatal and non-fatal myocardial infarction during a 10-year follow-up of a middle-aged male population with treatment of high-risk individuals.

  2009cited by this paper
• Omega-3 fatty acids and dementia.

  2009cited by this paper
• Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.

  2008cited by this paper
• Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk.

  2008cited by this paper
• Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study.

  2008cited by this paper
• n-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthood.

  2008cited by this paper
• n–3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood

  2008cited by this paper
• Role of Liver and Plasma Lipoproteins in Selective Transport of n-3 Fatty Acids to Tissues: A Comparative Study of 14C-DHA and 3H-Oleic Acid Tracers

  2007cited by this paper
• n 3 fatty acid proportions in plasma and cognitive performance in older adults.

  2007cited by this paper
• Alzheimer's Disease and Smoking: Bias in Cohort Studies

  2007cited by this paper
• Plasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities Study.

  2007cited by this paper
• Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up

  2006cited by this paper
• Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.

  2006cited by this paper
• Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

  2006cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop

  2006cited by this paper
• Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4.

  2005cited by this paper
• Benefits of fatty fish on dementia risk are stronger for those without APOE ε4

  2005cited by this paper
• Cumulative Incidence Estimation in the Presence of Competing Risks

  2004cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study.

  2003cited by this paper
• Biomarkers and the measurement of fatty acids

  2002cited by this paper
• Uses and limitations of statistical accounting for random error correlations, in the validation of dietary questionnaire assessments

  2002cited by this paper
• The cell biology of Alzheimer's disease: uncovering the secrets of secretases.

  2001cited by this paper
• Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease.

  2001cited by this paper
• Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects.

  2000cited by this paper
• De novo lipogenesis in humans: metabolic and regulatory aspects

  1999cited by this paper
• A Proportional Hazards Model for the Subdistribution of a Competing Risk

  1999cited by this paper
• The serum cholesterol ester fatty acid composition but not the serum concentration of alpha tocopherol predicts the development of myocardial infarction in 50-year-old men: 19 years follow-up.

  1996cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

  1996cited by this paper
• Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.

  1994cited by this paper
• Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects.

  1993cited by this paper
• Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing.

  1993cited by this paper
• Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

  1992cited by this paper
• Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper

• Mechanism analysis of Tongqiao Yizhi decoction in treating vascular dementia rats by brain tissue untargeted metabonomics and fecal 16S rRNA gene sequencing.

  2025cites this paper
• Association between serum tricosanoic acid and cognitive function in older adults: findings from the NHANES and GEO databases

  2025cites this paper
• The effects of rifaximin and lactulose on the gut-liver-brain axis in rats with minimal hepatic encephalopathy

  2025cites this paper
• The relationship of omega-3 fatty acids with dementia and cognitive decline: evidence from perspective cohort studies of supplementation, dietary intake, and blood markers.

  2023cites this paper
• TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia

  2023cites this paper
• The Effects of Amyloid-β on Metabolomic Profiles of Cardiomyocytes and Coronary Endothelial Cells

  2023cites this paper
• Modifiable Innate Biology within the Gut–Brain Axis for Alzheimer’s Disease

  2022cites this paper
• Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages

  2021cites this paper
• Case-cohort study of plasma phospholipid fatty acid profiles, cognitive function, and risk of dementia: a secondary analysis in the Ginkgo Evaluation of Memory Study.

  2021cites this paper
• Free Fatty Acids Are Associated with the Cognitive Functions in Stroke Survivors

  2021cites this paper
• Vegetarian Dietary Patterns and Cognitive Function among Older Adults: The Adventist Health Study-2

  2021cites this paper
• A Scoping Review of Dietary Factors Conferring Risk or Protection for Cognitive Decline in APOE ε4 Carriers

  2021cites this paper
• APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease

  2020cites this paper
• The role of peripheral fatty acids as biomarkers for Alzheimer's disease and brain inflammation.

  2020cites this paper
• Post-operative delirium associated with metabolic alterations following hemi-arthroplasty in older patients.

  2019cites this paper
• Independent Ageing in Very Old Swedish Men

  2019cites this paper
• Serum elaidic acid concentration and risk of dementia

  2019cites this paper
• Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4-/-: A double-blind, randomized, placebo-controlled crossover trial.

  2019cites this paper
• Nutrition and prevention of cognitive impairment.

  2018cites this paper
• Current Applications of Metabolomics in Cirrhosis

  2018cites this paper
• Evidence That Parietal Lobe Fatty Acids May Be More Profoundly Affected in Moderate Alzheimer’s Disease (AD) Pathology Than in Severe AD Pathology

  2018cites this paper
• Characterizing Alzheimer's disease through metabolomics and investigating anti‐Alzheimer's disease effects of natural products

  2017cites this paper
• Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E &egr;4 Carriers: A Review

  2017cites this paper
• Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis

  2016cites this paper
• Skyddar omega-3 mot demens?

  2016influential citation
• Searching the Linkage between High Fat Diet and Alzheimerâ²s Disease: A Debatable Proof Stand for Ketogenic Diet to Alleviate Symptoms of Alzheimerâ²s Patient with APOE õ4 Allele

  2016cites this paper
• Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis.

  2016cites this paper
• , BrainMercury Level , and APOE ε 4 StatusWithBrainNeuropathology inOlderAdults

  2016cites this paper
• Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults.

  2016cites this paper
• Molecular links between early energy metabolism alterations and Alzheimer's disease.

  2016cites this paper
• Slowing the progression of Alzheimer's disease; what works?

  2015cites this paper
• Brain function and glucocorticoids in obesity and type 2 diabetes including effects of lifestyle interventions

  2015cites this paper
• The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier?

  2015cites this paper
• Fatty acids rehabilitated long-term neurodegenerative: like symptoms in olfactory bulbectomized rats

  2015cites this paper
• Nutrition in the Prevention and Treatment of Cognitive Decline

  2015cites this paper
• PNS1300362 80..86

  2014cites this paper
• Polyunsaturated fatty acids and their metabolites in brain function and disease

  2014cites this paper
• Dietary fat composition and dementia risk.

  2014cites this paper
• Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.

  2014cites this paper
• Treatment Options for Covert Hepatic Encephalopathy

  2014cites this paper
• Biomarkers of fish oil omega-3 polyunsaturated fatty acids intake in humans.

  2014cites this paper
• Conference on ‘ PUFA mediators : implications for human health ’ Symposium 1 : PUFA : health effects and health claims Ageing and apoE change DHA homeostasis : relevance to age-related cognitive decline

  2014cites this paper
• Olfactory bulbectomy as a putative model for Alzheimer’: The protective role of essential fatty acids

  2014cites this paper
• Omega-3 Fatty Acids and Cognitive Behavior

  2014cites this paper
• Facteurs psychosociaux et nutritionnels des troubles cognitifs en Afrique Centrale

  2014cites this paper
• Early neuropsychological detection of Alzheimer's disease

  2014cites this paper
• Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease

  2014cites this paper
• Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype

  2013cites this paper
• Current evidence for the clinical use of long-chain polyunsaturated N-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease

  2013cites this paper
• Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy

  2013cites this paper
• Ageing and apoE change DHA homeostasis: relevance to age-related cognitive decline

  2013cites this paper
• World Journal of Biological Chemistry

  year unknowncites this paper